Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
about
Tamsulosin for benign prostatic hyperplasiaEffects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasiaPhytotherapy: emerging therapeutic option in urologic diseaseEjaculatory dysfunction in the treatment of lower urinary tract symptomsShrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract.Tamsulosin for benign prostatic hyperplasia.Medical treatment of benign prostatic hyperplasia.Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS)Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms.Is there a role for estrogens in the maintenance of men's health?Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract.The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.Saw palmetto and benign prostatic hyperplasia.Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)Preventing diseases of the prostate in the elderly using hormones and nutriceuticals.An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in menQuality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunctionPharmacological effects of saw palmetto extract in the lower urinary tractHair loss and herbs for treatment.Diagnosis and management of benign prostatic hyperplasia in primary care.Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).Real-world use of Permixon® in benign prostatic hyperplasia--determining appropriate monotherapy and combination treatment.Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice.Advances in the Medical Treatment of Prostate Cancer, Bladder Cancer, Renal Cell Cancer, and Benign Prostatic Hyperplasia: Highlights from the XVIIth Congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002
P2860
Q24234556-BF8574C2-7403-449F-8D42-52057F4D00C1Q24642371-0381F02C-E646-4A61-AFDF-7D32F39D6720Q26824548-C9FEFC9A-20AD-44F2-B551-33CF6ECAC2A9Q28073775-C1351B86-5EB9-4499-BA47-64DEF7483B4EQ30408737-63253FFE-4A62-4988-AE0B-ADDA977F0D60Q30882035-7F8E9A7A-FCF8-41E2-A573-2EC8D8F83057Q33588534-18995886-3BC0-4544-A176-D6B477EC6FE0Q34003918-8AFCD5CF-F291-40AB-8AC6-E0811CDD2EE3Q34485602-A483FCD9-65C1-4182-87F5-821F71E0240CQ35082993-0EB6A42B-D807-402E-B6F7-7B49D4FA33E3Q35854081-2122424F-6C60-4071-894A-1136E33D5B18Q35855002-4E0234DD-E6C5-4D87-B8EE-2FEF39545E2FQ35877386-7E75EF81-218D-4CC5-ABAE-F19733EE437FQ35919193-269F0028-FDCA-4F6D-9530-B06C7AFD1AA1Q36021075-D3593DB5-A5ED-4E59-818D-B54830F4D276Q36042592-5C279E32-0A72-4347-8B1A-86FEF7A10C89Q36820221-8AF72388-4835-4BF6-890C-068215BEC97EQ37305843-B8B0363E-EF62-418F-8DF0-A95336F92FE7Q37406930-169CBF35-1FFF-481C-95B4-EBC9653A9D00Q38132839-49749FBD-B8EB-40F2-BEEC-F55EDDDCB5E8Q41986288-2C12CDEC-0D51-4ED5-AE71-82B484140235Q44969928-2752AE17-6BC9-43A8-B77B-A0D918D6A554Q45422268-292979B5-8A2F-41B1-8224-6761020EF818Q46481688-FADE2C44-1988-4E0D-B488-8B2F709DFF68Q47694772-B31965DE-12A7-401C-A4E2-DD55FCB01764Q53236407-570588E1-56DA-4647-8C51-289D20682091Q57651757-E7A2A433-DC6D-4657-88CE-21D89B6E65AE
P2860
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Comparison of a phytotherapeut ...... andomized international study.
@en
Comparison of a phytotherapeutic agent
@nl
type
label
Comparison of a phytotherapeut ...... andomized international study.
@en
Comparison of a phytotherapeutic agent
@nl
prefLabel
Comparison of a phytotherapeut ...... andomized international study.
@en
Comparison of a phytotherapeutic agent
@nl
P2093
P1433
P1476
Comparison of a phytotherapeut ...... andomized international study.
@en
P2093
Fernando Calais Da Silva
Frans Debruyne
Freddie C Hamdy
Jay G Gillenwater
Jean-Pierre Raynaud
Paul Perrin
Pierre Teillac
Remigio Vela-Navarrete
P304
497-506; discussion 506-7
P356
10.1016/S0302-2838(02)00066-0
P407
P50
P577
2002-05-01T00:00:00Z